Spot gold was down 0.1% at $1,808.91 per ounce, after having hit its highest since Dec. 17 on Monday, while U.S. gold futures were up 0.1% at $1,810.00
Gold prices dropped from a one-week high in thin trading on Tuesday, as easing concerns over the Omicron coronavirus variant and strong U.S. retail sales data boosted risk appetite.
Spot gold was down 0.1% at $1,808.91 per ounce by 0328 GMT, after having hit its highest since Dec. 17 on Monday, while U.S. gold futures were up 0.1% at $1,810.00.
There’s lack of participation. So, any little nugget of cross-market correlation is going to make markets move, said Stephen Innes, managing partner at SPI Asset Management.
What the crux of the argument will be, and probably limit gold’s upside momentum, is real rates, which could rise as the economy recovers from this little slip they’ve had on Omicron, he said.
Asian shares advanced, cruising in the slipstream of another record-setting day on Wall Street, while the safe-haven yen lost ground as traders stayed in riskier currencies and asset classes.
Crude oil prices gained ground on expectations the Omicron variant would have only a limited impact on global demand.
The U.S. dollar, also viewed as a safe-haven, languished near the bottom end of its recent trading range versus a basket of peers, maintaining the greenback-priced gold’s appeal for holders of non-U.S. currencies, and limiting losses.
The two-year Treasury yield, which is sensitive to interest rate expectations, climbed to the highest in nearly 22 months in Tokyo, increasing the opportunity cost of holding bullion, which pays no interest.
Meanwhile, Japan’s jobless rate rose to 2.8% in November, while the availability of jobs matched that of the previous month, government data showed.
Spot silver dropped 0.3% to $22.98 an ounce, platinum fell 0.5% to $966.02, and palladium shed 0.9% to $1,953.97.
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.